Cargando…
Antiinflammatory Therapy in Clinical Care: The CANTOS Trial and Beyond
Inflammation is a critical pathway in the pathogenesis of atherosclerosis. Previous studies have shown that plasma levels of high-sensitivity C-reactive protein (hsCRP), a marker of inflammation, are associated with cardiovascular disease independent of traditional risk factors. Randomized trial dat...
Autores principales: | Aday, Aaron W., Ridker, Paul M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996084/ https://www.ncbi.nlm.nih.gov/pubmed/29922680 http://dx.doi.org/10.3389/fcvm.2018.00062 |
Ejemplares similares
-
Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease
por: Aday, Aaron W., et al.
Publicado: (2019) -
New Promises and Challenges on Inflammation and Atherosclerosis: Insights From CANTOS and CIRT Trials
por: Palmer, Raymond D., et al.
Publicado: (2019) -
Beyond MACE: a multidimensional approach to outcomes in clinical trials for older adults with stable ischemic heart disease
por: Kalra, Kriti, et al.
Publicado: (2023) -
Clinical Impact of Single and Dual Antiplatelet Therapy Beyond 12 Months on Ischemic Risk in Patients With Acute Myocardial Infarction
por: Roh, Ji Woong, et al.
Publicado: (2021) -
Inflammation and antiinflammatory therapy : proceedings of the International Symposium on Inflammation and Antiinflammatory Drugs, Mexico City, Mexico, February, 1974 /
Publicado: (1975)